Medicinova Stock Price

0.14 (2.57%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Medicinova Inc MNOV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.14 2.57% 5.58 20:00:00
Open Price Low Price High Price Close Price Prev Close
5.54 5.475 5.72 5.58 5.44
Bid Price Ask Price Spread News
5.37 6.60 1.23 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,149 229,943 $ 5.57 $ 1,281,190 253,098 2.79 - 13.25
Last Trade Time Type Quantity Stock Price Currency
16:22:43 formt 218 $ 5.58 USD

Medicinova Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 251.24M 45.02M 42.69M $ - $ - -0.29 -21.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Medicinova News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNOV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.936.045.435.69116,839-0.35-5.9%
1 Month5.786.765.436.09150,790-0.20-3.46%
3 Months6.006.764.99015.80207,995-0.42-7.0%
6 Months5.356.784.6315.75339,0760.234.3%
1 Year4.6313.252.798.53619,2350.9520.52%
3 Years10.9814.502.798.87283,062-5.40-49.18%
5 Years6.4214.502.798.53214,419-0.84-13.08%

Medicinova Description

MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of small molecule therapeutics segment.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.